BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bariwal J, Ma H, Altenberg GA, Liang H. Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment. Chem Soc Rev 2022. [PMID: 35156110 DOI: 10.1039/d1cs01074c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Li Q, Wang C, Hao Y, Yang N, Chen M, Ji J, Feng L, Liu Z. Rational Design of Biomaterials to Potentiate Cancer Thermal Therapy. Chem Rev 2023. [PMID: 36912061 DOI: 10.1021/acs.chemrev.2c00822] [Reference Citation Analysis]
2 Li W, Jiang Y, Lu J. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy. Int J Pharm 2023;634:122655. [PMID: 36720448 DOI: 10.1016/j.ijpharm.2023.122655] [Reference Citation Analysis]
3 Zhong G, Wang L, Jin H, Li X, Zhou D, Wang G, Lian R, Xie P, Zhang S, Zheng L, Qu X, Shen S, Shahbazi M, Xiao L, Li K, Gao J, Li Y. Tumor microenvironment double-responsive shrinkable nanoparticles fabricated via facile assembly of laponite with a bioactive oligosaccharide for anticancer therapy. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104344] [Reference Citation Analysis]
4 Tan X, Li S, Sheng R, Zhang Q, Li C, Liu L, Zhang Y, Ge L. Biointerfacial giant capsules with high paclitaxel loading and magnetic targeting for breast tumor therapy. J Colloid Interface Sci 2023;633:1055-68. [PMID: 36516681 DOI: 10.1016/j.jcis.2022.11.151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun L, Wang D, Noh I, Fang RH, Gao W, Zhang L. Synthesis of Erythrocyte Nanodiscs for Bacterial Toxin Neutralization. Angew Chem Int Ed Engl 2023;:e202301566. [PMID: 36853913 DOI: 10.1002/anie.202301566] [Reference Citation Analysis]
6 Xi H, Xu B, Fang A, Li X, Huang Z, Qin S, Xiao W, Li G, Tian M, Fan N, Song X. A cascade-responsive nanoplatform with tumor cell-specific drug burst release for chemotherapy. Acta Biomater 2023:S1742-7061(23)00103-4. [PMID: 36828165 DOI: 10.1016/j.actbio.2023.02.022] [Reference Citation Analysis]
7 Chen L, Yu C, Xu W, Xiong Y, Cheng P, Lin Z, Zhang Z, Knoedler L, Panayi AC, Knoedler S, Wang J, Mi B, Liu G. Dual-Targeted Nanodiscs Revealing the Cross-Talk between Osteogenic Differentiation of Mesenchymal Stem Cells and Macrophages. ACS Nano 2023;17:3153-67. [PMID: 36715347 DOI: 10.1021/acsnano.2c12440] [Reference Citation Analysis]
8 Xu D, Chen X, Li Y, Chen Z, Xu W, Wang X, Lv Y, Wang Z, Wu M, Liu G, Wang J. Reconfigurable Peptide Analogs of Apolipoprotein A-I Reveal Tunable Features of Nanodisc Assembly. Langmuir 2023. [PMID: 36626237 DOI: 10.1021/acs.langmuir.2c03082] [Reference Citation Analysis]
9 Lu S, Tian H, Li L, Li B, Yang M, Zhou L, Jiang H, Li Q, Wang W, Nice EC, Xie N, Huang C, Liu L. Nanoengineering a Zeolitic Imidazolate Framework-8 Capable of Manipulating Energy Metabolism against Cancer Chemo-Phototherapy Resistance. Small 2022;18:e2204926. [PMID: 36260824 DOI: 10.1002/smll.202204926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Noh I, Guo Z, Zhou J, Gao W, Fang RH, Zhang L. Cellular Nanodiscs Made from Bacterial Outer Membrane as a Platform for Antibacterial Vaccination. ACS Nano 2022. [PMID: 36441916 DOI: 10.1021/acsnano.2c08360] [Reference Citation Analysis]
11 Zhang J, Zhang T, Gao J. Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review. Nanomaterials 2022;12:3323. [DOI: 10.3390/nano12193323] [Reference Citation Analysis]
12 Xu R, Zhang D, Tan J, Ge N, Liu D, Liu J, Ouyang L, Zhu H, Qiao Y, Qiu J, Zhu S, Liu X. A Multifunctional Cascade Bioreactor Based on a Layered Double Oxides Composite Hydrogel for Synergetic Tumor Chemodynamic/Starvation/Photothermal Therapy. Acta Biomater 2022:S1742-7061(22)00587-6. [PMID: 36115653 DOI: 10.1016/j.actbio.2022.09.024] [Reference Citation Analysis]
13 Liu M, Svirskis D, Proft T, Loh J, Chen S, Kang D, Wen J. Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations. Int J Pharm 2022;625:122123. [PMID: 35995317 DOI: 10.1016/j.ijpharm.2022.122123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Xu Y, Yu Z, Fu H, Guo Y, Hu P, Shi J. Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. ACS Appl Mater Interfaces 2022;14:21836-47. [PMID: 35512029 DOI: 10.1021/acsami.2c00111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]